about
Volume criteria for the treatment of head and neck cancer: Are they evidence based?The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma.Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.Variation in head and neck cancer care in the Netherlands: A retrospective cohort evaluation of incidence, treatment and outcome.Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence.A critical evaluation of lymph node ratio in head and neck cancer.Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival.The influence of nodal yield in neck dissections on lymph node ratio in head and neck cancer.High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer.An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010).The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center.FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiationBioXmark® liquid fiducial markers for image guided radiotherapy in muscle invasive bladder cancer, a safety and performance trial
P50
Q38166324-97BC4F20-7C03-46DF-9E7D-D367F1FFDD86Q38654246-03A524ED-6057-4941-93B0-38B0ACE46BFEQ38735944-3C4AB011-49FB-452F-AFCA-F6DE5D3C1AB2Q38740716-0702AA69-679E-4F9A-B91B-F93C88397D9AQ38935251-F84F0E6A-03FD-4A1C-9064-370A06BA2764Q39378466-54B69DB7-3BBF-468F-BD25-B8BD69CDD442Q40429409-D7BCD338-FCBD-404E-BD35-9FD8185CA6D7Q43876133-C662EC31-3DBC-42D5-87C5-81ED1F54F118Q48215849-F68C36B4-07FC-4932-BFE7-2BE9B86E1997Q51267584-310B332B-D4D8-437F-A650-BD1FD6985C7FQ53073838-36DA419F-22B2-4FCD-8D32-F2FEE801FB50Q91542311-6611932C-9075-44D6-B5F8-EFB0C54B21FCQ95940106-F56E6952-53C3-4FED-8A68-6FAB91E1008C
P50
description
investigador
@es
researcher
@en
name
Mischa de Ridder
@en
type
label
Mischa de Ridder
@en
prefLabel
Mischa de Ridder
@en
P31
P496
0000-0002-2530-3038